Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03177616 · ClinicalTrials.gov registry record · NA

Integrative Migraine Pain Alleviation Through Chiropractic Therapy

A NA study of Migraine and Migraine Disorders, sponsored by Harvard University Faculty of Medicine.

Completed
Registry status
NA
Development phase
61
Enrollment target
1
Study location

NCT03177616 is a NA study of Migraine and Migraine Disorders that has completed, run by Harvard University Faculty of Medicine. The registered enrollment target is 61 participants, below the 358-participant average among 102 other Migraine trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03177616, a NA study of Migraine and Migraine Disorders, has completed, sponsored by Harvard University Faculty of Medicine.

COMPLETED
Registry status
NA
Development phase
61 participants
Enrollment target
1
Study location

Study Summary

This pilot study evaluates the addition of chiropractic treatment to conventional neurological care in the treatment of migraine headaches in adult women. Half of the participants will receive 10 chiropractic treatments in addition to their usual care over a 14 week period, while the other half will continue their usual medical care alone, as prescribed by their physician during that time period.

Interventions

  • OTHER Chiropractic Treatment

Study Locations (1)

Massachusetts

  • The Osher Clinical Center for Integrative Medicine at Brigham and Women's Hospital - Boston

Trial Details

FieldValue
Enrollment Target 61 participants
Start Date 2017-06-07
Est. Completion 2022-11-04
Phase NA

What the Registry Record Tells You About NCT03177616

The ClinicalTrials.gov registry entry for NCT03177616 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 61 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 358-participant average among 102 other Migraine trials with a reported enrollment target (83% lower). The listed sponsor is Harvard University Faculty of Medicine, which has 9 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Migraine appearing as the primary indexed condition, and to 1 intervention - of which Chiropractic Treatment is the first listed.

NCT03177616 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT03177616 about?

NCT03177616 is a clinical study titled "Integrative Migraine Pain Alleviation Through Chiropractic Therapy". This pilot study evaluates the addition of chiropractic treatment to conventional neurological care in the treatment of migraine headaches in adult women. Half of the participants will receive 10 chiropractic treatments in addition to their usual care over a 14 week period, while the other half will...

What is the current status of trial NCT03177616?

This trial is currently completed. It is a NA study. The enrollment target is 61 participants. The study started on 2017-06-07. Estimated completion is 2022-11-04.

What conditions does trial NCT03177616 study?

This clinical trial studies the following conditions: Migraine, Migraine Disorders, Migraine With Aura, Migraine Without Aura, Migraine, Classic.

What interventions are being tested in trial NCT03177616?

The interventions under investigation include: Chiropractic Treatment (OTHER).

Who is sponsoring clinical trial NCT03177616?

This trial is sponsored by Harvard University Faculty of Medicine, which has 9 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03177616 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Migraine

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.